Hematologic Malignancies: Chaired by Marc Braunstein, MD, PhD

December 14, 2020

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of hematologic malignancies.

Hematologic Malignancies: Chaired by Marc Braunstein, MD, PhD

The live filming of this virtual event in our IPC series is now on-demand.

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of oncology.

Speakers

  • Marc Braunstein, MD, PhD | Perlmutter Cancer Center at NYU Langone - Long Island
  • Shella Saint Fleur-Lominy, MD, PhD | Perlmutter Cancer Center at NYU Langone
  • Andrew M. Evens, DO, MSc, FACP | Rutgers Cancer Institute of New Jersey
  • Jacqueline Claudia Barrientos, MD | Northwell Health Cancer Institute

Topics

  • Myeloproliferative Neoplasms
  • Hodgkin Lymphoma/ Peripheral T-Cell Lymphoma
  • Multiple Myeloma: Novel Agents
  • Chronic Lymphocytic Leukemia: Choosing a Frontline Therapy
x